检索历史清除

首页> Haematologica> A phase I study of escalated dose subcutaneous alemtuzumab given weekly with rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma

A phase I study of escalated dose subcutaneous alemtuzumab given weekly with rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma

导出原文传递

翻译打印收藏纠错

作者： Brown,J.R. ^[1] ; Messmer,B. ; Werner,L. ; Davids,M.S. ; Mikler,E. ; Supko,J.G. ; Fisher,D.C. ; LaCasce,A.S. ; Armand,P. ; Jacobsen,E. ; Dalton,V. ; Tesar,B. ; Fernandes,S.M. ; McDonough,S. ; Ritz,J. ; Rassenti,L. ; Kipps,T.J. ; Neuberg,D. ; Freedman,A.S.

作者单位： Department of Medical Oncology, Department of Biostatistics and Computational Biology, Dana-Farber ^[1]

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交